Avalo 制药 AVTX
$6.93 +$0.30 (+4.52%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $7.05 +1.73%
开盘$6.90
昨收$6.63
当日区间$6.53 – $7.01
成交量1.11M
市值$400.71M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例136.4%-0.75 个百分点，较上季度
持仓机构数160+9 ，较上季度
内部人近期交易20次买入 / 30次卖出净卖出
空头持仓比例22.31% 占流通股回补天数 13.0 · 截至 15 Oct 2026
卖空成交量占比17.2%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$5.51M（4个净流入日，16个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有37.1%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从24.48%降至22.31%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| BlackRock | Mutual Fund | 2026/Q3 | +4,038,471 | 8.1% |
| Deep Track Capital, LP | VC/PE Fund | 2026/Q3 | +3,610,000 | 6.7% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +2,817,633 | 5.4% |
| TCG Crossover Management, LLC | VC/PE Fund | 2026/Q3 | +2,278,737 | 5.6% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,782,926 | 4.8% |
| Braidwell LP | Hedge Fund | 2026/Q3 | +1,629,182 | 3.0% |
| Farallon Capital Management, L.L.C. | Hedge Fund | 2026/Q3 | +1,582,000 | 4.7% |
| Affinity Asset Advisors, LLC | Hedge Fund | 2026/Q3 | +1,559,160 | 5.4% |
| Caligan Partners, LP | Hedge Fund | 2026/Q3 | +1,528,843 | 5.9% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,470,884 | 4.5% |
| Bank of America Corporation | Public Company | 2026/Q3 | +1,270,829 | 3.6% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +1,260,689 | 2.4% |
| Soleus Capital Management, L.P. | Hedge Fund | 2026/Q3 | +1,213,000 | 3.1% |
| Geode Capital Management, LLC | Mutual Fund | 2026/Q3 | +935,229 | 2.1% |
| Avoro Capital Advisors LLC | Hedge Fund | 2026/Q3 | +923,333 | 4.4% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 29 Sep 2026 | Kevin Lind | Independent Director | Other Derivative Acquisition | +1,352 | $15.33 | 1,352 |
| 29 Sep 2026 | Rita Jain | Independent Director | Other Derivative Acquisition | +1,322 | $15.33 | 1,322 |
| 29 Sep 2026 | Ron Philip | Independent Director | Other Derivative Acquisition | +1,109 | $15.33 | 1,109 |
| 15 Sep 2026 | Christopher Sullivan | CFO & Head of Investor relations | Derivative Exercise and Sale | -12,394 | $16.33 | 39,900 |
| 9 Sep 2026 | Christopher Sullivan | CFO & Head of Investor relations | Derivative Exercise and Sale | -10,185 | $17.62 | 39,900 |
| 27 Aug 2026 | Mittie Doyle | Chief Medical Officer | Derivative Exercise and Sale | -679 | $20.00 | 8,276 |
| 17 Aug 2026 | Christopher Sullivan | CFO & Head of Investor relations | Derivative Exercise and Sale | -71,852 | $20.05 | – |
| 16 Aug 2026 | Mittie Doyle | Chief Medical Officer | Derivative Exercise and Sale | -1,000 | $20.00 | 8,276 |
| 16 Aug 2026 | Christopher Sullivan | CFO & Head of Investor relations | Open Market Disposition | -873 | $19.94 | – |
| 10 Aug 2026 | Jennifer Riley | Chief Strategy Officer | Open Market Disposition | -2,655 | $19.59 | 2,841 |
| 9 Aug 2026 | Mittie Doyle | Chief Medical Officer | Derivative Exercise and Sale | -679 | $20.00 | 8,276 |
| 26 Jul 2026 | Mittie Doyle | Chief Medical Officer | Derivative Exercise and Sale | -1,000 | $20.00 | 8,276 |
| 29 Jun 2026 | Kevin Lind | Independent Director | Other Derivative Acquisition | +1,105 | $18.48 | 1,105 |
| 29 Jun 2026 | Mittie Doyle | Chief Medical Officer | Derivative Exercise and Sale | -4,654 | $20.00 | 8,276 |
| 29 Jun 2026 | Rita Jain | Independent Director | Other Derivative Acquisition | +1,080 | $18.48 | 1,080 |
| 29 Jun 2026 | Ron Philip | Independent Director | Other Derivative Acquisition | +69 | $18.48 | 69 |
| 22 Jun 2026 | Mittie Doyle | Chief Medical Officer | Derivative Exercise and Sale | -1,450 | $18.00 | 8,276 |
| 22 Jun 2026 | Ron Philip | Independent Director | Other Derivative Acquisition | +40,200 | $17.83 | 40,200 |
| 9 Jun 2026 | Mittie Doyle | Chief Medical Officer | Sale to Issuer | -1,084 | $13.10 | 8,276 |
| 9 Jun 2026 | Paul Varki | Chief Legal Officer | Sale to Issuer | -1,081 | $13.10 | 8,276 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 11,963,625 | 22.3% | 13.0 |
| 30 Sep 2026 | 11,405,304 | 21.3% | 8.8 |
| 15 Sep 2026 | 12,925,869 | 24.1% | 13.2 |
| 31 Aug 2026 | 12,387,012 | 23.1% | 15.2 |
| 14 Aug 2026 | 13,092,767 | 24.4% | 20.2 |
| 31 Jul 2026 | 12,950,314 | 24.5% | 14.4 |
暂无评论——快来第一个聊聊 AVTX。
登录后参与讨论。